ArticleFrontiers in immunology2025

Immunomodulatory peptide-drug conjugate MEL-dKLA suppresses progression of prostate cancer by eliminating M2-like tumor-associated macrophages.

Ik-Hwan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.